YiHe Technology Secures Two Financing Rounds to Accelerate the Industrialization of Electrochemical Synthesis
Want to read in a language you're more familiar with?
YiHe Technology, a Hunan University-backed startup pioneering scalable green electrochemical synthesis, has secured tens of millions of RMB across angel and angel+ rounds to challenge global chemical giants with safer, lower-cost production of pharmaceutical and agrochemical intermediates.
December 5, 2025 — YiHe Technology, a company specializing in the R&D and industrialization of electrochemical synthesis, has completed two consecutive funding rounds totaling tens of millions of RMB, including an angel round led by K2VC and an angel+ round funded by angel investor Fei Gesheng. The proceeds will be used for team expansion, process optimization, and pilot-scale product development. Yuewei Capital served as the exclusive financial advisor for subsequent rounds.
YiHe Technology is backed by a strong scientific and engineering team. CEO Jin Qingfeng, who brings over 20 years of chemical engineering experience, previously led major advanced-materials projects. Hunan University professors Wang Shuangyin and Zou Yuqin serve as Chief Scientist and Head of R&D, contributing deeply to core technology development.
The company focuses on electrochemical synthesis — a process that uses electrons as the “reagent” to drive chemical reactions. This method offers lower cost, higher safety, and strong selectivity, making it suitable for producing fine chemicals and pharmaceutical intermediates, while supporting the traditional chemical industry’s transition toward greener, low-carbon processes.
YiHe has already built a complete production system, spanning reaction systems, catalysts, reactor engineering, and purification processes. Its proprietary Fluid-Guided Electrolyzer (FGE) technology addresses mass- and heat-transfer challenges that typically hinder industrial-scale electrochemical production. The team is also developing a “process–performance” database and a digital twin model, expected to reduce new-product development cycles by over 50%.
YiHe’s next-phase product pipeline covers pharmaceutical and agrochemical intermediates, with a goal to achieve commercial production of 5–8 high-value products by the end of 2026. The company aims to break the dominance of global chemical giants and position itself as both a technological benchmark and cost leader in electrochemical synthesis.
